Ranbaxy plummeted for the second day in row on BSE on Tuesday with its shares closing a whopping over 14 per cent amid the US Department of Justice filing a motion against the company in a district court of Maryland alleging
fraudulent activities.
Ranbaxy settled the day at Rs 409.25, down 14.01 per cent, or Rs 66.65, from its last close.
It touched an an intra-day low of Rs 402.50, lower by over 15 per cent from its previous close after opening at Rs 478, its intra-day high.
Meanwhile, shareholders of Ranbaxy Laboratories
id="div_arti_inline_advt">